Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-08-13 07:23:28 UTC |
---|
Update Date | 2023-02-21 17:16:51 UTC |
---|
HMDB ID | HMDB0003929 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 5-Aminoimidazole |
---|
Description | Because of its ability to mimic a low energy status of the cell, the cell-permeable nucleoside 5-aminoimidazole-4-carboxamide (AICA) riboside was proposed as an antineoplastic agent switching off major energy-consuming processes associated with the malignant phenotype (lipid production, DNA synthesis, cell proliferation, cell migration, etc.). Key to the antineoplastic action of AICA riboside is its conversion to ZMP, an AMP mimetic that at high concentrations activates the AMP-activated protein kinase (AMPK). (PMID: 16985054 ). |
---|
Structure | InChI=1S/C3H5N3/c4-3-1-5-2-6-3/h1-2H,4H2,(H,5,6) |
---|
Synonyms | Value | Source |
---|
Aminoimidazole | Kegg | 4-Aminoimidazole | Kegg | 5-Aminoimidazole | ChEBI |
|
---|
Chemical Formula | C3H5N3 |
---|
Average Molecular Weight | 83.0919 |
---|
Monoisotopic Molecular Weight | 83.048347175 |
---|
IUPAC Name | 1H-imidazol-5-amine |
---|
Traditional Name | 5-aminoimidazole |
---|
CAS Registry Number | 4919-03-3 |
---|
SMILES | NC1=CN=CN1 |
---|
InChI Identifier | InChI=1S/C3H5N3/c4-3-1-5-2-6-3/h1-2H,4H2,(H,5,6) |
---|
InChI Key | QRZMXADUXZADTF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminoimidazoles. These are organic compounds containing an amino group linked to an imidazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Imidazoles |
---|
Direct Parent | Aminoimidazoles |
---|
Alternative Parents | |
---|
Substituents | - Aminoimidazole
- Heteroaromatic compound
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
5-Aminoimidazole,1TMS,isomer #1 | C[Si](C)(C)NC1=CN=C[NH]1 | 1321.4 | Semi standard non polar | 33892256 | 5-Aminoimidazole,1TMS,isomer #1 | C[Si](C)(C)NC1=CN=C[NH]1 | 1222.3 | Standard non polar | 33892256 | 5-Aminoimidazole,1TMS,isomer #1 | C[Si](C)(C)NC1=CN=C[NH]1 | 2094.1 | Standard polar | 33892256 | 5-Aminoimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C=NC=C1N | 1305.8 | Semi standard non polar | 33892256 | 5-Aminoimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C=NC=C1N | 1206.3 | Standard non polar | 33892256 | 5-Aminoimidazole,1TMS,isomer #2 | C[Si](C)(C)N1C=NC=C1N | 2028.8 | Standard polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #1 | C[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C | 1258.1 | Semi standard non polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #1 | C[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C | 1412.1 | Standard non polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #1 | C[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C | 1832.9 | Standard polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #2 | C[Si](C)(C)NC1=CN=CN1[Si](C)(C)C | 1419.7 | Semi standard non polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #2 | C[Si](C)(C)NC1=CN=CN1[Si](C)(C)C | 1366.1 | Standard non polar | 33892256 | 5-Aminoimidazole,2TMS,isomer #2 | C[Si](C)(C)NC1=CN=CN1[Si](C)(C)C | 1947.4 | Standard polar | 33892256 | 5-Aminoimidazole,3TMS,isomer #1 | C[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 1487.1 | Semi standard non polar | 33892256 | 5-Aminoimidazole,3TMS,isomer #1 | C[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 1493.3 | Standard non polar | 33892256 | 5-Aminoimidazole,3TMS,isomer #1 | C[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C)[Si](C)(C)C | 1585.7 | Standard polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CN=C[NH]1 | 1518.5 | Semi standard non polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CN=C[NH]1 | 1430.7 | Standard non polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC1=CN=C[NH]1 | 2303.3 | Standard polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC=C1N | 1524.1 | Semi standard non polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC=C1N | 1384.1 | Standard non polar | 33892256 | 5-Aminoimidazole,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C=NC=C1N | 2165.5 | Standard polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 1680.2 | Semi standard non polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 1808.9 | Standard non polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=C[NH]1)[Si](C)(C)C(C)(C)C | 1971.5 | Standard polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CN=CN1[Si](C)(C)C(C)(C)C | 1878.1 | Semi standard non polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CN=CN1[Si](C)(C)C(C)(C)C | 1794.9 | Standard non polar | 33892256 | 5-Aminoimidazole,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC1=CN=CN1[Si](C)(C)C(C)(C)C | 2138.3 | Standard polar | 33892256 | 5-Aminoimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2129.6 | Semi standard non polar | 33892256 | 5-Aminoimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2095.2 | Standard non polar | 33892256 | 5-Aminoimidazole,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C1=CN=CN1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1903.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminoimidazole GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9000000000-b7f12da8e2a5e1822034 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 5-Aminoimidazole GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 10V, Positive-QTOF | splash10-001i-9000000000-775bbd8098911ec4aa11 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 20V, Positive-QTOF | splash10-0a59-9000000000-075581ac53eac2cff1cc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 40V, Positive-QTOF | splash10-054o-9000000000-63146729dde1e3b109e2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 10V, Negative-QTOF | splash10-001i-9000000000-ef930e78c28038c9badf | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 20V, Negative-QTOF | splash10-053r-9000000000-0acc92e0f19da4e18a20 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 40V, Negative-QTOF | splash10-014i-9000000000-c8e07ecd5bf1e8146136 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 10V, Negative-QTOF | splash10-001i-9000000000-3c279b1eddb7eb96d639 | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 20V, Negative-QTOF | splash10-001i-9000000000-f5a9901a1d655bdceefb | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 40V, Negative-QTOF | splash10-014l-9000000000-2655b37ef52173453d6c | 2021-09-21 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 10V, Positive-QTOF | splash10-001i-9000000000-cc88d9cd94ae7b2c176d | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 20V, Positive-QTOF | splash10-0a5c-9000000000-72413771e65dbb225a23 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 5-Aminoimidazole 40V, Positive-QTOF | splash10-052f-9000000000-b8c30c58a1f18729c4c4 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
General References | - Laikind PK, Seegmiller JE, Gruber HE: Detection of 5'-phosphoribosyl-4-(N-succinylcarboxamide)-5-aminoimidazole in urine by use of the Bratton-Marshall reaction: identification of patients deficient in adenylosuccinate lyase activity. Anal Biochem. 1986 Jul;156(1):81-90. [PubMed:3740420 ]
- Beckers A, Organe S, Timmermans L, Vanderhoydonc F, Deboel L, Derua R, Waelkens E, Brusselmans K, Verhoeven G, Swinnen JV: Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside. Mol Cancer Ther. 2006 Sep;5(9):2211-7. [PubMed:16985054 ]
|
---|